Comparative immunogenicity and neutralizing antibody responses post heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) in HIV-infected patients with varying CD4+ T lymphocyte counts

The immune response to heterologous coronavirus disease (COVID-19) vaccination in people living with HIV (PLWH) is still unclear. Herein, our prospective cohort study aimed to compare the immune response of heterologous vaccination with CoronaVac (Sinovac) and Vaxzevria (AstraZeneca) between PLWH ha...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sorawit Chittrakarn, Pisud Siripaitoon, Sarunyou Chusri, Siripen Kanchanasuwan, Boonsri Charoenmak, Thanaporn Hortiwakul, Phaiwon Kantikit, Narongdet Kositpantawong
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Taylor & Francis Group 2024-12-01
Saila:	Human Vaccines & Immunotherapeutics
Gaiak:	COVID-19 people living with HIV SARS-CoV-2 vaccine anti-receptor-binding domain immunoglobulin G neutralizing antibodies
Sarrera elektronikoa:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2309734
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!